• 0
    Loading cart contents...
Search
Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing BR1008
Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing BR1008
BR1008a
BioCoreUSA row: 10; column: 10; cores: 100; cases: 100
Breast cancer tissue array with matched adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251
Breast cancer tissue array with matched adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251
FMG251a
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 47 cases/80 cores, replacing BR802
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 47 cases/80 cores, replacing BR802
BR802b
BioCoreUSA row: 8; column: 10; cores: 80; cases: 47
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d
FMG08013e
BioCoreUSA row: 8; column: 9; cores: 72; cases: 72
Colon cancer tissue/matched normal tissue array with survival data, including survival status, pathology grade, TNM and clinical stage, 80 cases/160 cores
Colon cancer tissue/matched normal tissue array with survival data, including survival status, pathology grade, TNM and clinical stage, 80 cases/160 cores
S-CRAC3204M
BioCoreUSA row: 10; column: 16; cores: 160; cases: 80
Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue
Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue
CO952a
TissueArray each
Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores
Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores
FMG1001
BioCoreUSA row: 10; column: 10; cores: 100; cases: 96
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma
KD951a
TissueArray each
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e
FMG08013f
BioCoreUSA row: 8; column: 9; cores: 72; cases: 72
Different stages bladder cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 27 cases/54 cores
Different stages bladder cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 27 cases/54 cores
UBD541
BioCoreUSA row: 7; column: 8; cores: 54; cases: 27
Bladder cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 10 cases/24 cores, replacing BL241
Bladder cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 10 cases/24 cores, replacing BL241
BL241a
BioCoreUSA row: 4; column: 6; cores: 24; cases: 10
Breast cancer tissue array, with adjacent normal tissue and cancer adjacent breast tissue, including pathology grade,TNM and clinical stage, 45 cases/63 cores
Breast cancer tissue array, with adjacent normal tissue and cancer adjacent breast tissue, including pathology grade,TNM and clinical stage, 45 cases/63 cores
FMG631
BioCoreUSA row: 7; column: 9; cores: 63; cases: 45
Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores
Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores
BRC051
BioCoreUSA row: 1; column: 5; cores: 5; cases: 5
Multiple types breast cancer tissue array with adjacent normal tissue, including pathology grade and IHC markers (ER, Her-2), TNM and clinical stage, 102 cases/102 cores
Multiple types breast cancer tissue array with adjacent normal tissue, including pathology grade and IHC markers (ER, Her-2), TNM and clinical stage, 102 cases/102 cores
FMG1021
BioCoreUSA row: 8; column: 13; cores: 102; cases: 102
Breast cancer tissue array with adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 75 cases/150 cores
Breast cancer tissue array with adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 75 cases/150 cores
FMG1504
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c
BR251d
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b
FMG251c
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a
Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a
BR1201b
BioCoreUSA row: 10; column: 12; cores: 120; cases: 60
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing BR248
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing BR248
BR248a
BioCoreUSA row: 4; column: 6; cores: 24; cases: 24
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483
FMG483b
BioCoreUSA row: 6; column: 8; cores: 48; cases: 48
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483b
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483b
FMG483c
BioCoreUSA row: 6; column: 8; cores: 48; cases: 48
Breast cancer tissue array with adjacent normal tissue, including pathology gradeand and IHC marker (ER, PR Ki-67and Her-2), TNM and clinical stage, 6 cases/24 cores
Breast cancer tissue array with adjacent normal tissue, including pathology gradeand and IHC marker (ER, PR Ki-67and Her-2), TNM and clinical stage, 6 cases/24 cores
FMG247
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast cancer with adjacent normal tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, repalcing BR245a
Breast cancer with adjacent normal tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, repalcing BR245a
FBR-245b
BioCoreUSA row: 4; column: 6; cores: 24; cases: 12
Breast carcinoma (HR) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 71 cases/142 cores.
Breast carcinoma (HR) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 71 cases/142 cores.
S-FMG142M
BioCoreUSA row: 11; column: 14; cores: 142; cases: 71
Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 54 cases/80 cores, replacing BR802b
Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 54 cases/80 cores, replacing BR802b
FMG802c
BioCoreUSA row: 8; column: 10; cores: 80; cases: 54
Breast carcinoma (Her2 3+) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 70 cases/140 cores.
Breast carcinoma (Her2 3+) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 70 cases/140 cores.
S-FMG140M
BioCoreUSA row: 12; column: 12; cores: 140; cases: 70
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
BR20832
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
BR20833
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
BR20834
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
BR20835
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Bladder cancer tissue array with cancer adjacent tissue, including TNM and clinical stage, 12 cases/24 cores, replacing BL243
Bladder cancer tissue array with cancer adjacent tissue, including TNM and clinical stage, 12 cases/24 cores, replacing BL243
UBD243a
BioCoreUSA row: 4; column: 6; cores: 24; cases: 12
Bladder cancer tissue array with adjacent normal tissue, including TNM and clinical stage, 24 cases/72 cores
Bladder cancer tissue array with adjacent normal tissue, including TNM and clinical stage, 24 cases/72 cores
UBD721
BioCoreUSA row: 8; column: 9; cores: 72; cases: 24
Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue
Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue
LC953
TissueArray each
Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208
Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208
UBD208a
BioCoreUSA row: 12; column: 16; cores: 192; cases: 64
Breast cancer tissue array with lymph node positive and negative, with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 120 cases/ 132 cores
Breast cancer tissue array with lymph node positive and negative, with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 120 cases/ 132 cores
BR1321
BioCoreUSA row: 12; column: 11; cores: 132; cases: 120
Breast carcinoma tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing BR245
Breast carcinoma tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing BR245
FMG246
BioCoreUSA row: 4; column: 6; cores: 24; cases: 12
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b
BR2085c
BioCoreUSA row: 13; column: 16; cores: 208; cases: 188
Lung small cell carcinoma and normal tissue microarray with survival data, including TNM and clinical stage, 68 cases/68 cores.
Lung small cell carcinoma and normal tissue microarray with survival data, including TNM and clinical stage, 68 cases/68 cores.
S-SCLC1361M
BioCoreUSA row: 7; column: 10; cores: 68; cases: 68
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b
BR1504c
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
Bone tumor and adjacent normal tissue array, including TNM and clinical stage, 24 cases/48 cores, replacing BM483b
Bone tumor and adjacent normal tissue array, including TNM and clinical stage, 24 cases/48 cores, replacing BM483b
LBN483c
BioCoreUSA row: 6; column: 8; cores: 48; cases: 24
Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue and metastatic carcinoma tissue array
Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue and metastatic carcinoma tissue array
ES2001b
TissueArray each
Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores
Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores
BR1510
BioCoreUSA row: 10; column: 15; cores: 150; cases: 50
Colorectal cancer with matched lymph node metastasis carcinoma and normal adjacent or cancer adjacent tissue array
Colorectal cancer with matched lymph node metastasis carcinoma and normal adjacent or cancer adjacent tissue array
CO992b
TissueArray each
Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores
Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores
FMG010
BioCoreUSA row: 3; column: 4; cores: 10; cases: 10
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 4 cases/8 cores, replacing BR082
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 4 cases/8 cores, replacing BR082
FMG082a
BioCoreUSA row: 2; column: 4; cores: 8; cases: 4
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases/48 cores) with stage and grade info
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases/48 cores) with stage and grade info
ES481
TissueArray each
Breast invasive ductal carcinoma tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR808, BC08014
Breast invasive ductal carcinoma tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR808, BC08014
BR8018
BioCoreUSA row: 8; column: 10; cores: 80; cases: 80
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505e
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505e
BR1505f
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006a
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006a
BR1006b
BioCoreUSA row: 10; column: 10; cores: 100; cases: 50
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505b
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505b
FMG1505c
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75